CMS Open Payments Deadlines and What Happens If You Miss Them

Every year, pharmaceutical and medical device companies that have made payments or transfers of value to healthcare professionals in the United States face the same deadline: submit your Open Payments report to CMS by March 31st. For some companies, particularly those reporting for the first time, or those managing a high volume of transactions, that date can arrive faster than expected.

Understanding the full timeline and what is at stake if you miss it altogether is essential knowledge for any life science company operating in the US market.

The Core Reporting Calendar

CMS Open Payments reporting follows a set annual cycle tied to the previous calendar year’s activity. Applicable manufacturers are required to report all payments and transfers of value made to covered recipients such as physicians, non-physician practitioners, and teaching hospitals, during the preceding year. The key dates in the reporting cycle are:

CMS currently lists the Open Payments data submission period as February 1 through March 31. For the 2025 program year, CMS materials show April 1–May 15, 2026 for the main review/dispute/correction period, May 16–May 30, 2026 for additional corrections on outstanding disputes, and public posting on or by June 30, 2026.

Penalties for Non-Compliance

Failure to report can trigger civil monetary penalties, and CMS notes that these amounts are adjusted annually for inflation. As of the 2026 adjustment, penalties for non-knowing failures can reach $14,432 per payment or other transfer of value, capped at $216,490 annually, while knowing failures can reach $144,329 per payment, capped at $1,443,275 annually.

Beyond the direct financial penalties, late or missing submissions can attract regulatory scrutiny, create reputational risk, and complicate relationships with the healthcare professionals who were not reported accurately or on time.

Common Reasons Companies Miss the Deadline

• Lack of an internal process to track all HCP interactions throughout the year
• Difficulty obtaining accurate NPI numbers and licence information for covered recipients
• Uncertainty about which transactions are reportable versus non-reportable
• First-time filers underestimating the time required to register with the CMS Open Payments system
• Internal review and approval processes that are not initiated early enough
• (CMS Open Payments validation errors, system jams near the deadline etc)

How to Avoid a Deadline Crisis

The most effective protection against a deadline problem is a continuous, year-round tracking process rather than a year-end scramble. Companies should maintain a live register of all HCP engagements, capturing the key reporting fields, recipient details, transaction date, amount, nature of payment, and state, at the time the engagement occurs, not months later.

First-time filers should allow time to create a CMS Identity Management (IDM) account and request access to the Open Payments system.

If you find yourself close to the deadline and unprepared, the most important thing is to submit what you have accurately rather than delaying in pursuit of perfection.

Do not let deadline pressure turn a straightforward reporting obligation into a compliance crisis. Vector Health Compliance’s US transparency reporting solutions help pharmaceutical and medical device companies build year-round processes that make Open Payments filing accurate, timely, and stress-free. Explore our services to future-proof your CMS reporting programme.

Table of content

• The Core Reporting Calendar
• Penalties for Non-Compliance
• Common Reasons Companies Miss the Deadline
• How to Avoid a Deadline Crisis

Every year, pharmaceutical and medical device companies that have made payments or transfers of value to healthcare professionals in the United States face the same deadline: submit your Open Payments report to CMS by March 31st. For some companies, particularly those reporting for the first time, or those managing a high volume of transactions, that date can arrive faster than expected.

Understanding the full timeline and what is at stake if you miss it altogether is essential knowledge for any life science company operating in the US market.

The Core Reporting Calendar

CMS Open Payments reporting follows a set annual cycle tied to the previous calendar year’s activity. Applicable manufacturers are required to report all payments and transfers of value made to covered recipients such as physicians, non-physician practitioners, and teaching hospitals, during the preceding year. The key dates in the reporting cycle are:

CMS currently lists the Open Payments data submission period as February 1 through March 31. For the 2025 program year, CMS materials show April 1–May 15, 2026 for the main review/dispute/correction period, May 16–May 30, 2026 for additional corrections on outstanding disputes, and public posting on or by June 30, 2026.

Penalties for Non-Compliance

Failure to report can trigger civil monetary penalties, and CMS notes that these amounts are adjusted annually for inflation. As of the 2026 adjustment, penalties for non-knowing failures can reach $14,432 per payment or other transfer of value, capped at $216,490 annually, while knowing failures can reach $144,329 per payment, capped at $1,443,275 annually.

Beyond the direct financial penalties, late or missing submissions can attract regulatory scrutiny, create reputational risk, and complicate relationships with the healthcare professionals who were not reported accurately or on time.

Common Reasons Companies Miss the Deadline

• Lack of an internal process to track all HCP interactions throughout the year
• Difficulty obtaining accurate NPI numbers and licence information for covered recipients
• Uncertainty about which transactions are reportable versus non-reportable
• First-time filers underestimating the time required to register with the CMS Open Payments system
• Internal review and approval processes that are not initiated early enough
• (CMS Open Payments validation errors, system jams near the deadline etc)

How to Avoid a Deadline Crisis

The most effective protection against a deadline problem is a continuous, year-round tracking process rather than a year-end scramble. Companies should maintain a live register of all HCP engagements, capturing the key reporting fields, recipient details, transaction date, amount, nature of payment, and state, at the time the engagement occurs, not months later.

First-time filers should allow time to create a CMS Identity Management (IDM) account and request access to the Open Payments system.

If you find yourself close to the deadline and unprepared, the most important thing is to submit what you have accurately rather than delaying in pursuit of perfection.

Do not let deadline pressure turn a straightforward reporting obligation into a compliance crisis. Vector Health Compliance’s US transparency reporting solutions help pharmaceutical and medical device companies build year-round processes that make Open Payments filing accurate, timely, and stress-free. Explore our services to future-proof your CMS reporting programme.

Author

Umer Tanweer leads the Global Compliance & Analytics function at Vector Health Compliance. His expertise includes multi-country transparency reporting, cross-border value transfer disclosure, and the remediation of compliance systems and processes. At Vector Health, he oversees the design and deployment of advanced analytics frameworks for compliance monitoring, working across regulatory, data science, and operational teams to ensure integrity, scalability, and global alignment.

Vector Health Compliance
Your Leading Partner in Global Sunshine Compliance